8-K current report · filed Sep 3, 2026

Immunovant, Inc. (IMVT) 8-K Current Report: September 3, 2026

Item 5.07IMVT overview

Short answer

Immunovant, Inc. (IMVT) filed an 8-K current report with the SEC on September 3, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 198,373,370 shares represented, approximately 96% of eligible voting shares, indicating strong shareholder participation.

Immunovant, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • 198,373,370 shares represented, approximately 96% of eligible voting shares, indicating strong shareholder participation
  • Bauer, Hughes, and Susman re-elected to the Board through the 2027 annual meeting
  • Ernst & Young ratified as independent auditor for fiscal year ending March 31, 2027, with 198,148,265 votes for
  • Executive compensation approved on a non-binding advisory basis, with 180,772,822 votes for
  • Director elections and compensation approval support management continuity, despite 8,437,839 votes opposing pay practices

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Immunovant, Inc. 8-K filings

Get the next IMVT 8-K as it lands

Follow IMVT for push alerts, or ask the research agent what this filing means.